Drug Development, Drug Trials and Pharmaceutical Companies

Advanced 3D cell-based technologies

Drug Target Review

SEPTEMBER 19, 2023

In addition, these models at the current state are better for short term tests, over a week or two and cannot be used for acquiring data from long term drug exposures. Miniature organs as test beds for new drugs Organoids are miniature human organs with clusters of cells derived from stem cells and mimic specific tissues.

Animal Testing

Animal Testing Clinical Trials Pharmaceutical Companies FDA

An Evolving Regulatory Environment for Rare and Orphan Diseases

Advarra

AUGUST 16, 2022

The Orphan Drug Act of 1983 was instrumental in changing the number of orphan drugs approved in the U.S. The law established the Office of Orphan Products Development , providing financial incentives for pharmaceutical companies to develop orphan drugs and making it more viable to invest in orphan drug research and development.

Disease

Disease Clinical Trials FDA Approval FDA

Drug Discovery Digest

Advanced 3D cell-based technologies

An Evolving Regulatory Environment for Rare and Orphan Diseases

Webinars

Stay Connected